Outcome indicators in randomized controlled trials on traditional Chinese medicine intervention of sepsis-induced myocardial injury in recent five years.
10.19540/j.cnki.cjcmm.20220529.503
- Author:
Li-Xin LIANG
1
;
Zi-Hao LIU
2
;
De-Huai LONG
2
;
Hong-Xu LIU
2
Author Information
1. Beijing Hospital of Traditional Chinese Medicine, Capital Medical University Beijing 100010, China Shunyi Branch, Beijing Hospital of Traditional Chinese Medicine Beijing 101300, China.
2. Beijing Hospital of Traditional Chinese Medicine, Capital Medical University Beijing 100010, China.
- Publication Type:Journal Article
- Keywords:
myocardial injury;
outcome indicator;
randomized controlled trial;
sepsis;
traditional Chinese medicine
- MeSH:
Drugs, Chinese Herbal/therapeutic use*;
Humans;
Medicine, Chinese Traditional;
Randomized Controlled Trials as Topic;
Sepsis/drug therapy*;
Treatment Outcome
- From:
China Journal of Chinese Materia Medica
2022;47(18):5088-5096
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to analyze the outcome indicators of randomized controlled trial(RCT) on traditional Chinese medicine(TCM) intervention of sepsis-induced myocardial injury(SIMI) in recent five years, which is expected to lay a basis for the construction of core outcome set(COS) for this disease treated by TCM. To be specific, RCT on the treatment of SIMI with TCM was retrieved from 4 Chinese databases, 3 English databases, and 2 clinical trial protocol registries. The quality of the included studies was evaluated with Cochrane risk-of-bias(ROB) tool, and the outcome indicators were analyzed. Finally, 42 RCTs were included, of which 2 were clinical trial registration schemes. The study found that 42 RCTs had a high risk of bias, and reported a total of 86 indicators in "clinical effective rate, disease severity, TCM syndrome score, inflammation, myocardium, cardiac structure and hemodynamics, electrocardiogram, immunology, metabolism and liver and kidney function, and safety". Outcome indicators on myocardium had the highest emergence frequency, followed by indicators on the cardiac structure and hemodynamics. A total of 8 RCTs reported TCM syndrome scores. Further analysis suggested the following problems in the selection of outcome indicators in the RCTs on TCM intervention of SIMI: no classification of primary and secondary indicators, disregard of endpoint indicators, irrational selection of alternative indicators, neglection of TCM characteristics, no assessment of patients' immune status, and no emphasis on economic indicators and safety indicators. Therefore, according to the recommendations of the core outcome measures in effectiveness trials(COMET) working group, a COS for TCM intervention of TCM for SIMI should be developed, so as to facilitate clinical researchers to select appropriate outcome indicators, the combination of conclusions of similar clinical studies, and the promotion of TCM interventions.
